Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment

Spremljeno u:
Bibliografski detalji
Izdano u:Cell Mol Immunol
Glavni autori: Guo, Yelei, Feng, Kaichao, Tong, Chuan, Jia, Hejin, Liu, Yang, Wang, Yao, Ti, Dongdong, Yang, Qingming, Wu, Zhiqiang, Han, Weidong
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Correspondence
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7109086/
https://ncbi.nlm.nih.gov/pubmed/31900459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-019-0355-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items